Skip to main content

Formulations of Extemporaneous Subconjunctival Injections

  • Chapter
  • First Online:
Extemporaneous Ophthalmic Preparations

Abstract

In this chapter, the most common four formulations are presented and discussed following a systematic methodology starting with the composition and drug family, followed by use, dose, and preparation. The preparation is discussed in detail in terms of concentration(s), procedure, expiration date, storage, packaging, and special precautions.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 49.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 64.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 89.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Reynolds LA, Closson RG. Extemporaneous ophthalmic preparations. Am J Ophthalmol. 1994;117(2):277.

    Article  Google Scholar 

  2. Trissel LA. Trissel’s stability of compounded formulations. 4th ed. Washington DC: American Pharmacists Association; 2009. p. 26–7.

    Google Scholar 

  3. Doctor PP, Bhat PV, Foster CS. Subconjunctival bevacizumab for corneal neovascularization. Cornea. 2008;27(9):992–5.

    Article  PubMed  Google Scholar 

  4. Genentech. Avastin. Summary of product characteristics. (2010). Available at http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000582/WC500029271.pdf. Accessed Jul 2012.

  5. Novartis. Lucentis summary of product characteristics. (2012). Available at https://www.medicines.org.uk/emc/history/19409/SPC/Lucentis+10+mg+ml+solution+for+injection. Accessed Jul 2012.

  6. Jenkins CD, McDonnell PJ, Spalton DJ. Randomised single blind trial to compare the toxicity of subconjunctival gentamicin and cefuroxime in cataract surgery. Br J Ophthalmol. 1990;74(12):734–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Trissel LA, Allwood MC, Haas DP, Hale KN, American Society of Hospital Pharmacists. Handbook on injectable drugs, vol. 14. Bethesda: American Society of Health-System Pharmacists; 2007.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Alghamdi, E.A.S., Al Qahtani, A.Y., Sinjab, M.M., Alyahya, K.M. (2020). Formulations of Extemporaneous Subconjunctival Injections. In: Extemporaneous Ophthalmic Preparations. Springer, Cham. https://doi.org/10.1007/978-3-030-27492-4_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-27492-4_14

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-27491-7

  • Online ISBN: 978-3-030-27492-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics